NCT02796755View on ClinicalTrials.gov

Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

October 24, 2019

Study Completion Date

October 24, 2019

Conditions
InflammationFatigue
Interventions
DRUG

Riluzole

Study participants randomized to this arm will take 100 mg/day of riluzole for 8 weeks.

DRUG

Placebo

Study participants randomized to this arm will take a placebo, that matches the appearance of 100 mg tablets of riluzole, daily for 8 weeks.

Trial Locations (1)

30322

Emory University Winship Cancer Institute, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT02796755 - Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation | Biotech Hunter | Biotech Hunter